rt-PA for Stroke: Why the Reluctance?

recombinant, tissue, plasminogen, activator, acute, ischemic, stroke, emergency, department, rt-PA, intercerebral, hemorrhage, NINDS, National Institute of Neurological Disorders and Stroke trialrecombinant, tissue, plasminogen, activator, acute, ischemic, stroke, emergency, department, rt-PA, intercerebral, hemorrhage, NINDS, National Institute of Neurological Disorders and Stroke trial

recombinant, tissue, plasminogen, activator, acute, ischemic, stroke, emergency, department, rt-PA, intercerebral, hemorrhage, NINDS, National Institute of Neurological Disorders and Stroke trialrecombinant, tissue, plasminogen, activator, acute, ischemic, stroke, emergency, department, rt-PA, intercerebral, hemorrhage, NINDS, National Institute of Neurological Disorders and Stroke trial

recombinant, tissue, plasminogen, activator, acute, ischemic, stroke, emergency, department, rt-PA, intercerebral, hemorrhage, NINDS, National Institute of Neurological Disorders and Stroke trialrecombinant, tissue, plasminogen, activator, acute, ischemic, stroke, emergency, department, rt-PA, intercerebral, hemorrhage, NINDS, National Institute of Neurological Disorders and Stroke trial